Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fospropofol vs Propofol in Elective Coronary Artery Surgery
NCT00209521Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jun 2002
- Primary completion
- Jul 2003
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
Phase 2, randomised, open-label trial of fospropofol disodium in coronary artery disease (CAD) (2 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Median time to loss of consciousness from induction start at Day 1. Started Jun 2002; status: completed.
02
Drugs
fospropofol disodium
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00209521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00209521.